322M 12.5/500 (Alogliptin Benzoate and Metformin Hydrochloride 12.5 mg / 500 mg)
Pill with imprint 322M 12.5/500 is Yellow, Elliptical / Oval and has been identified as Alogliptin benzoate and metformin hydrochloride 12.5 mg / 500 mg. It is supplied by Perrigo New York Inc..
Alogliptin/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Alogliptin/metformin 12.5 mg / 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for 322M 12.5/500
Alogliptin benzoate and metformin hydrochloride
- Imprint:
- 322M 12.5/500
- Strength:
- 12.5 mg / 500 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Perrigo New York Inc.
- National Drug Code (NDC):
- 45802-0169
More about alogliptin/metformin
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1 Review – Add your own review/rating
- Drug class: antidiabetic combinations
Consumer resources
Other brands: Kazano
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
